Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Xi'an Jiaotong UniversityActive in the last 2 years

Fangshi Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2282-4743; OpenAlex author ID A5078325945. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2021: 2 papers · 2022: 2 papers · 2023: none · 2024: 1 paper

Papers 5

  1. Endoplasmic reticulum stress regulators exhibit different prognostic, therapeutic and immune landscapes in pancreatic adenocarcinoma. Co-author DOI 10.1111/jcmm.18092↗
  2. Pyroptosis regulators exert crucial functions in prognosis, progression and immune microenvironment of pancreatic adenocarcinoma: a bioinformatic and in vitro … First author DOI 10.1080/21655979.2021.2019873↗
  3. SLC1A5 Prefers to Play as an Accomplice Rather Than an Opponent in Pancreatic Adenocarcinoma. Co-author DOI 10.3389/fcell.2022.800925↗
  4. Bioinformatic mining and validation of the effects of ferroptosis regulators on the prognosis and progression of pancreatic adenocarcinoma. Co-author DOI 10.1016/j.gene.2021.145804↗
  5. M6A Regulatory Genes Play an Important Role in the Prognosis, Progression and Immune Microenvironment of Pancreatic Adenocarcinoma. Co-author DOI 10.1080/07357907.2020.1834576↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Honghong Pei · 3 shared papers, 2021–2022 · strength 0.50
  2. Zhengliang Zhang · 3 shared papers, 2021–2022 · strength 0.47
  3. Ling Bai · 2 shared papers, 2021 · strength 0.31
  4. Shanshan Liu · 1 shared paper, 2024 · strength 0.23
  5. Bin‐cheng Ren · 1 shared paper, 2024 · strength 0.23
  6. Yu Shi · 1 shared paper, 2022 · strength 0.17
  7. Zhenghai Bai · 1 shared paper, 2022 · strength 0.17
  8. Bincheng Ren · 1 shared paper, 2022 · strength 0.16
  9. Hai Wang · 1 shared paper, 2022 · strength 0.16
  10. Honghong Pei · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.